Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

EIGER BIOPHARMACEUTICALS, INC.

(EIGR)
  Rapport
Vertraagde tijd Nasdaq  -  22:00:00 27-01-2023
1.420 USD   +1.43%
23/01Codexis benoemt financieel directeur
MT
2022Insider Kopen: Eiger Biopharmaceuticals
MT
2022Eiger BioPharmaceuticals Chief Executive David Cory neemt ontslag; interim CEO benoemd
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
ETF's gepositioneerd op EIGER BIOPHARMACEUTICALS, INC.ETF's en trackers met Trackinsight
ETF gewichtVariatie 5 dagenRatingGeografie
IShares Micro-Cap ETF - USD0.06%1.46%VS
Invesco Nasdaq Biotechnology ETF - USD0.04%1.95%-VS
IShares Nasdaq US Biotechnology (D) - USD0.03%1.83%VS
IShares Nasdaq US Biotechnology - USD0.03%1.78%VS
IShares Biotechnology ETF - USD0.03%1.30%-NC
IShares Russell 2000 Growth ETF - USD0.03%2.54%VS
Vanguard Russell 2000 Growth ETF - USD0.03%3.76%VS
Vanguard Russell 2000 ETF - USD0.02%2.46%VS
Xtrackers Russell 2000 1C - USD0.01%2.49%VS
IShares Russell 2000 ETF - USD0.01%3.58%VS
Vanguard Russell 2000 Value ETF - USD0%3.62%VS



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ďInformationĒ) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Grafiek EIGER BIOPHARMACEUTICALS, INC.
Duur : Periode :
Eiger BioPharmaceuticals, Inc. : Grafische technische analyse Eiger BioPharmaceuticals, Inc. | MarketScreener
Grafiek op volledig scherm
Evolutie van de resultatenrekening
Consensus
Verkoop
Koop
Gemiddeld advies Kopen
Aantal analisten 5
Laatste slotkoers 1,42 $
Gemiddelde koersdoel 9,20 $
Spread / Gemiddelde doel 548%
Grafiek EIGER BIOPHARMACEUTICALS, INC.
Duur : Periode :
Eiger BioPharmaceuticals, Inc. : Grafische technische analyse Eiger BioPharmaceuticals, Inc. | MarketScreener
Grafiek op volledig scherm
Sector en concurrentie
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
EIGER BIOPHARMACEUTICALS, INC.18.64%63
MODERNA, INC.7.58%72 745
LONZA GROUP AG17.24%42 787
IQVIA HOLDINGS INC.12.00%42 622
ALNYLAM PHARMACEUTICALS, INC.-2.55%28 465
SEAGEN INC.9.46%26 117